DexCom, Inc.
DXCM
$73.43
-$0.95-1.28%
NASDAQ
| 12/31/2025 | 09/30/2025 | 06/30/2025 | 03/31/2025 | 12/31/2024 | |
|---|---|---|---|---|---|
| Revenue | 4.66B | 4.52B | 4.30B | 4.15B | 4.03B |
| Total Other Revenue | -- | -- | -- | -- | -- |
| Total Revenue | 4.66B | 4.52B | 4.30B | 4.15B | 4.03B |
| Cost of Revenue | 1.86B | 1.85B | 1.77B | 1.68B | 1.59B |
| Gross Profit | 2.80B | 2.67B | 2.53B | 2.47B | 2.44B |
| SG&A Expenses | 1.29B | 1.30B | 1.27B | 1.28B | 1.29B |
| Depreciation & Amortization | -- | -- | -- | -- | -- |
| Other Operating Expenses | -- | -- | -- | -- | -- |
| Total Operating Expenses | 3.75B | 3.74B | 3.61B | 3.52B | 3.43B |
| Operating Income | 911.80M | 777.70M | 687.20M | 632.60M | 600.00M |
| Income Before Tax | 1.09B | 959.00M | 784.10M | 730.80M | 709.00M |
| Income Tax Expenses | 252.10M | 238.30M | 212.60M | 195.60M | 132.80M |
| Earnings from Continuing Operations | 836.30 | 720.70 | 571.50 | 535.20 | 576.20 |
| Earnings from Discontinued Operations | -- | -- | -- | -- | -- |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | -- | -- | -- | -- | -- |
| Net Income | 836.30M | 720.70M | 571.50M | 535.20M | 576.20M |
| EBIT | 911.80M | 777.70M | 687.20M | 632.60M | 600.00M |
| EBITDA | 1.16B | 1.02B | 923.30M | 857.80M | 817.70M |
| EPS Basic | 2.14 | 1.84 | 1.46 | 1.36 | 1.46 |
| Normalized Basic EPS | 1.74 | 1.53 | 1.25 | 1.16 | 1.13 |
| EPS Diluted | 2.09 | 1.80 | 1.43 | 1.33 | 1.42 |
| Normalized Diluted EPS | 1.68 | 1.47 | 1.20 | 1.11 | 1.08 |
| Average Basic Shares Outstanding | 1.56B | 1.56B | 1.57B | 1.58B | 1.57B |
| Average Diluted Shares Outstanding | 1.62B | 1.63B | 1.63B | 1.64B | 1.65B |
| Dividend Per Share | -- | -- | -- | -- | -- |
| Payout Ratio | -- | -- | -- | -- | -- |